KMID : 0882420040670010094
|
|
Korean Journal of Medicine 2004 Volume.67 No. 1 p.94 ~ p.99
|
|
A case of posttransplantation lymphoproliferative disease developed in renal transplant recipient and treated with rituximab
|
|
Park Ui-Soon
Choi Chan-Bum Kim In-Soon Choi Il-Young Kang Chong-Myung Park Chan-Kum Ahn Myung-Ju
|
|
Abstract
|
|
|
Posttransplant lymphoproliferative disorder (PTLD) are among the most serious and potentially fatal complications of chronic immunosuppression in organ transplant recipient and also the most common malignancies, accounting for 21 percent of all malignancies in organ transplants versus 5 percent of malignancies in the general population. PTLD is associated with immunosuppression and Epstein Barr virus (EBV). Treatment modality of PTLD includes antiviral agent, interferon, intensive chemotherapy and monoclonal antibody. Choice of treatment modality depends on clinical presentation of PTLD. We report here a case of PTLD involving liver and renal allograft treated with rituximab.(Korean J Med 67:94-99, 2004)
|
|
KEYWORD
|
|
Posttransplant lymphoproliferative disorder, Rituximab, Renal transplantation
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|